Oxford Immunotec Global News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.02.21	Oxford Immunotec Enters a Memorandum of Understanding (MOU) with GC MS (Green Cross Medical Science Corp. – South Korea) to Market the T-SPOT® Discovery SARS-CoV-2 Kit, for the Measurement of the T Ce (GlobeNewswire)
04.02.21	Oxford Immunotec Updates Their T-SPOT® Discovery SARS-CoV-2 Kit and Include a New Panel to Detect T Cells Reactive to Endemic Coronaviruses (GlobeNewswire)
14.01.21	New Monthly Series Spotlights What 100 Physicians Find to be Critical Needs in Their Battle Against COVID-19 (GlobeNewswire)
13.01.21	Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of Valneva’s VLA2001 COVID-19 Vaccine Candidate in a Phase I/II Clinical Study (GlobeNewswire)
07.01.21	PerkinElmer To Acquire Oxford Immunotec - Quick Facts (RTTNews)
16.12.20	Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week (GlobeNewswire)
10.12.20	Oxford Immunotec Announces the Approval of the T-Cell Select™ Reagent Kit, Used to Automate the T-SPOT®.TB Test Workflow, for IVD Use in South Korea (GlobeNewswire)
02.12.20	Oxford Immunotec Signs Exclusive Distributor Agreement with RIKEN Genesis, a Subsidiary of Sysmex, to Market the T-SPOT® Discovery SARS-CoV-2 Kit for the Measurement of the T cell Immune Response to S (GlobeNewswire)
23.11.20	Oxford Immunotec to Hold a Virtual Investor Event on December 17, 2020 (GlobeNewswire)
10.11.20	Data Showing SARS-CoV-2 Reactive T Cells are Associated with Protection from COVID-19 – and Can Be Both Detected and Measured Using Oxford Immunotec’s T-SPOT® Technology – is Published by Public Healt (GlobeNewswire)
05.11.20	Oxford Immunotec Files Submission to Food and Drug Administration (FDA) for the T-Cell Select™ Reagent Kit (GlobeNewswire)
03.11.20	Oxford Immunotec Reports Third Quarter 2020 Financial Results (GlobeNewswire)
02.11.20	Ausblick: Oxford Immunotec Global stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
22.10.20	UK Vaccines Taskforce has Selected Oxford Immunotec as the Sole Supplier of T cell Testing for SARS-CoV-2 Specific Responses in New COVID Vaccine Trials (GlobeNewswire)
21.10.20	Oxford Immunotec Schedules Third Quarter 2020 Earnings Release and Conference Call for November 3, 2020 (GlobeNewswire)
29.09.20	Oxford Immunotec Announces Food and Drug Administration (FDA) Clearance of the T-SPOT®.TB Test for Use in Pediatrics Over the Age of Two (GlobeNewswire)
22.09.20	Oxford Immunotec Joins Forces with Public Health England (PHE) in a Large Clinical Trial Utilizing T-SPOT® Discovery™ SARS-CoV-2 Test (GlobeNewswire)
04.08.20	Oxford Immunotec Reports Second Quarter 2020 Financial Results (GlobeNewswire)
03.08.20	Ausblick: Oxford Immunotec Global mit Zahlen zum abgelaufenen Quartal (finanzen.net)
21.07.20	Oxford Immunotec Schedules Second Quarter 2020 Earnings Release and Conference Call for August 4, 2020 (GlobeNewswire)
20.07.20	Oxford Immunotec Announces Agreement with Stop TB Partnership - Global Drug Facility (GDF) to Provide Access to the T-SPOT®.TB Test for 100+ TB Burden Countries (GlobeNewswire)
19.05.20	Oxford Immunotec releases the T-SPOT® Discovery™ SARS-CoV-2 kit for research into measuring the T cell immune response to SARS-CoV-2, which may offer new insights into immunity to COVID-19 (GlobeNewswire)
05.05.20	Oxford Immunotec Reports First Quarter 2020 Financial Results (GlobeNewswire)
29.04.20	Oxford Immunotec Schedules First Quarter 2020 Earnings Release and Conference Call for May 5, 2020 (GlobeNewswire)
21.04.20	Oxford Immunotec announces successful re-registration of the T-SPOT®.TB test in China (GlobeNewswire)
02.03.20	Oxford Immunotec Reports Fourth Quarter and Full Year 2019 Financial Results (GlobeNewswire)
01.03.20	Ausblick: Oxford Immunotec Global vermeldet Zahlen zum jüngsten Quartal (finanzen.net)
27.02.20	Oxford Immunotec to Present at the Cowen and Company 40th Annual Health Care Conference (GlobeNewswire)
24.02.20	Oxford Immunotec Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call for March 2, 2020 (GlobeNewswire)
20.02.20	Oxford Immunotec Announces New Data on the Utility of T-SPOT®.CMV in Kidney and Stem Cell Transplant (GlobeNewswire)
23.01.20	Oxford Immunotec Announces Donation in Support of Coronavirus Testing Efforts to Help Differentiate Tuberculosis from the New China Virus (GlobeNewswire)
06.01.20	Oxford Immunotec to Present at the 38th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
25.11.19	Oxford Immunotec to Participate in Two Investor Conferences (GlobeNewswire)
05.11.19	Oxford Immunotec Reports Third Quarter 2019 Financial Results (GlobeNewswire)
22.10.19	Oxford Immunotec Schedules Third Quarter 2019 Earnings Release and Conference Call for November 5, 2019 (GlobeNewswire)
21.08.19	Oxford Immunotec to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
06.08.19	Oxford Immunotec Reports Second Quarter 2019 Financial Results (GlobeNewswire)
04.08.19	Ausblick: Oxford Immunotec Global stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net)
18.07.19	Oxford Immunotec Schedules Second Quarter 2019 Earnings Release and Conference Call for August 6, 2019 (GlobeNewswire)
24.06.19	Oxford Immunotec Appoints Patrick J. Balthrop, Sr. as Chairman (GlobeNewswire)
17.05.19	Oxford Immunotec Welcomes Updated CDC Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel (GlobeNewswire)
14.05.19	Oxford Immunotec to Present at the UBS Global Healthcare Conference (GlobeNewswire)
09.05.19	Oxford Immunotec Reports First Quarter 2019 Financial Results (GlobeNewswire)
07.05.19	Ausblick: Oxford Immunotec Global veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net)
25.04.19	Oxford Immunotec Schedules First Quarter 2019 Earnings Release and Conference Call for May 9, 2019 (GlobeNewswire)
28.03.19	Oxford Immunotec Announces New Initiative to Bring the Benefit of Modern Tuberculosis Testing to the Russian Federation (GlobeNewswire)
21.03.19	Oxford Immunotec Announces Chief Financial Officer Transition (GlobeNewswire)
11.03.19	Oxford Immunotec Reports Fourth Quarter and Full Year 2018 Financial Results (GlobeNewswire)
09.03.19	Ausblick: Oxford Immunotec Global stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
05.03.19	Oxford Immunotec to Participate in Two Upcoming Investor Conferences (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nestle	84.14	2.19 %	K V
Sika	239.70	1.65 %	K V
Logitech Intl	94.10	1.25 %	K V
Kuehne+Nagel Int	215.10	0.89 %	K V
Geberit	529.60	0.88 %	K V
ABB	52.42	0.11 %	K V
Part Grp Hldg	1’394.50	0.07 %	K V
Swiss Re	138.30	-0.04 %	K V
Swiss Life Hldg	762.40	-0.08 %	K V
Zurich Insur Gr	574.40	-0.14 %	K V

Nachrichten zu Oxford Immunotec Global PLC

Aktien Top/Flop

Meistgelesene Nachrichten